default-logo
  • Technology
    • Our Adjuvants
    • Our Pipeline
    • Our Patents
  • News & Events
  • About
    • ImmunAdd at a Glance
    • Team Members
    • Our Philosophy
  • Contact
  • EN
  • 繁中
default-logo
  • Home
  • Technology
    • Our Adjuvants
    • Our Pipeline
    • Our Patents
  • News & Events
  • About
    • ImmunAdd at a Glance
    • Team Members
    • Our Philosophy
  • Contact
  • 繁中

News & Events

ImmunAdd Formally Names Its Next-Generation Synthetic Adjuvant Platform ImmSygma™; Adjuvant System Renamed IA-541
News

ImmunAdd Formally Names Its Next-Generation Synthetic Adjuvant Platform ImmSygma™; Adjuvant System Renamed IA-541

2026-07-19
ImmunAdd Actively Attends International Conferences to Expand Technology Licensing
News

ImmunAdd Actively Attends International Conferences to Expand Technology Licensing

2026-07-12
As of January 2026: 14 Patents Granted
News

As of January 2026: 14 Patents Granted

2026-01-22
ImmunAdd Inc. to Exhibit at BIO Asia–Taiwan 2025, Showcasing Innovations in Vaccine Adjuvant Development
Events News

ImmunAdd Inc. to Exhibit at BIO Asia–Taiwan 2025, Showcasing Innovations in Vaccine Adjuvant Development

2025-07-18
ImmunAdd Inc. to Showcase Next-Generation Saponin Adjuvants at 2025 BIO International Convention in Boston
Events

ImmunAdd Inc. to Showcase Next-Generation Saponin Adjuvants at 2025 BIO International Convention in Boston

2025-06-13
  • 1
  • 2
  • 3
  • ...
  • 5

Home

Technology

Our Pipeline

Our Adjuvants

Our Patents

About

Immunadd at a Glance

Team Members

Our Philosophy

News&Event

Contact

ImmunAdd Inc.

GUI: 90379709

Address: 11F-8, No. 130, Sec. 2, Zhongxiao E. Rd., Zhongzheng Dist. Taipei City 100411, Taiwan (R. O. C.)

© 2024 immunadd. All rights reserved.